The transcription factor MEF2C negatively controls angiogenic sprouting of endothelial cells depending on oxygen

PLoS ONE

Volumn 9, Issue 7, 2014, Pages

  Sturtzel, Caterina ^a   Testori, Julia ^a,b   Schweighofer, Bernhard ^a,c   Bilban, Martin ^a   Hofer, Erhard ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

^b AUSTRIAN AGENCY FOR HEALTH AND FOOD SAFETY   (Austria)

^c Universitatsklinik fur Dermatologie   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 MACROGLOBULIN; HISTONE DEACETYLASE; NOTCH RECEPTOR; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR MEF2C; UNCLASSIFIED DRUG; MEF2C PROTEIN, HUMAN; MYOCYTE ENHANCER FACTOR 2; OXYGEN; VASCULOTROPIN A;

A2M GENE; ANGIOGENESIS; ARTICLE; CELL GROWTH; CELL MIGRATION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME INHIBITION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE INDUCTION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; MEF2C GENE; NEGATIVE FEEDBACK; NUCLEOTIDE SEQUENCE; OXYGEN CONCENTRATION; OXYGEN TISSUE LEVEL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN INDUCTION; PROTEIN SECRETION; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; UPREGULATION; CYTOLOGY; HEK293 CELL LINE; METABOLISM; UMBILICAL VEIN ENDOTHELIAL CELL;

ALPHA-MACROGLOBULINS; CELL PROLIFERATION; ENDOTHELIAL CELLS; HEK293 CELLS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MEF2 TRANSCRIPTION FACTORS; NEOVASCULARIZATION, PHYSIOLOGIC; OXYGEN; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84903773288     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0101521     Document Type: Article

References (44)

1. Dvorak HF, Brown LF, Detmar M, Dvorak AM (1995) Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis. Am J Pathol 146: 1029-1039.
2. Semenza GL (2003) Targeting HIF-1 for cancer therapy. Nat Rev Cancer 3: 721-732.
3. Phng LK, Gerhardt H (2009) Angiogenesis: a team effort coordinated by notch. Dev Cell 16: 196-208.
4. Hofer E, Schweighofer B (2007) Signal transduction induced in endothelial cells by growth factor receptors involved in angiogenesis. Thromb Haemost 97: 355-363. (Pubitemid 46437796)
5. Koch S, Tugues S, Li X, Gualandi L, Claesson-Welsh L (2011) Signal transduction by vascular endothelial growth factor receptors. Biochem J 437: 169-183.
6. Schweighofer B, Testori J, Sturtzel C, Sattler S, Mayer H, et al. (2009) The VEGF-induced transcriptional response comprises gene clusters at the crossroad of angiogenesis and inflammation. Thromb Haemost 102: 544-554.
7. Liu D, Jia H, Holmes DI, Stannard A, Zachary I (2003) Vascular endothelial growth factor-regulated gene expression in endothelial cells: KDR-mediated induction of Egr3 and the related nuclear receptors Nur77, Nurr1, and Nor1. Arterioscler Thromb Vasc Biol 23: 2002-2007. (Pubitemid 37433192)
8. Zhao D, Desai S, Zeng H (2011) VEGF stimulates PKD-mediated CREBdependent orphan nuclear receptor Nurr1 expression: role in VEGF-induced angiogenesis. Int J Cancer 128: 2602-2612.
9. Liu D, Evans I, Britton G, Zachary I (2008) The zinc-finger transcription factor, early growth response 3, mediates VEGF-induced angiogenesis. Oncogene 27: 2989-2998. (Pubitemid 351668006)
10. Testori J, Schweighofer B, Helfrich I, Sturtzel C, Lipnik K, et al. (2011) The VEGF-regulated transcription factor HLX controls the expression of guidance cues and negatively regulates sprouting of endothelial cells. Blood 117: 2735-2744.
11. Rivera CG, Mellberg S, Claesson-Welsh L, Bader JS, Popel AS (2011) Analysis of VEGF - a regulated gene expression in endothelial cells to identify genes linked to angiogenesis. PLoS One 6: e24887.
12. del Toro R, Prahst C, Mathivet T, Siegfried G, Kaminker JS, et al. (2010) Identification and functional analysis of endothelial tip cell-enriched genes. Blood 116: 4025-4033.
13. Bi W, Drake CJ, Schwarz JJ (1999) The transcription factor MEF2C-null mouse exhibits complex vascular malformations and reduced cardiac expression of angiopoietin 1 and VEGF. Dev Biol 211: 255-267. (Pubitemid 29343280)
14. Wojta J, Hoover RL, Daniel TO (1989) Vascular origin determines plasminogen activator expression in human endothelial cells. Renal endothelial cells produce large amounts of single chain urokinase type plasminogen activator. J Biol Chem 264: 2846-2852. (Pubitemid 19057779)
15. Ingram DA, Mead LE, Tanaka H, Meade V, Fenoglio A, et al. (2004) Identification of a novel hierarchy of endothelial progenitor cells using human peripheral and umbilical cord blood. Blood 104: 2752-2760. (Pubitemid 39434958)
16. Green MR, Sambrook J (2012) Molecular cloning: a laboratory manual. Cold Spring Harbor, N.Y.: Cold Spring Harbor Laboratory Press. 3 v. (xxxiii, 1890, 1846 p.) p.1161, Calcium phosphate mediated Transfection of Cells with High-Molecular-Weight Genomic DNA.
17. Tauber S, Jais A, Jeitler M, Haider S, Husa J, et al. (2010) Transcriptome analysis of human cancer reveals a functional role of heme oxygenase-1 in tumor cell adhesion. Mol Cancer 9: 200.
18. Vichai V, Kirtikara K (2006) Sulforhodamine B colorimetric assay for cytotoxicity screening. Nat Protoc 1: 1112-1116.
19. Korff T, Augustin HG (1998) Integration of endothelial cells in multicellular spheroids prevents apoptosis and induces differentiation. J Cell Biol 143: 1341-1352. (Pubitemid 28559834)
20. Maiti D, Xu Z, Duh EJ (2008) Vascular endothelial growth factor induces MEF2C and MEF2-dependent activity in endothelial cells. Invest Ophthalmol Vis Sci 49: 3640-3648.
21. Critser PJ, Voytik-Harbin SL, Yoder MC (2011) Isolating and defining cells to engineer human blood vessels. Cell Prolif 44 Suppl 1: 15-21.
22. Pallavi SK, Ho DM, Hicks C, Miele L, Artavanis-Tsakonas S (2012) Notch and Mef2 synergize to promote proliferation and metastasis through JNK signal activation in Drosophila. EMBO J 31: 2895-2907.
23. Wilson-Rawls J, Molkentin JD, Black BL, Olson EN (1999) Activated notch inhibits myogenic activity of the MADS-Box transcription factor myocyte enhancer factor 2C. Mol Cell Biol 19: 2853-2862. (Pubitemid 29144529)
24. Zhang CL, McKinsey TA, Chang S, Antos CL, Hill JA, et al. (2002) Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy. Cell 110: 479-488. (Pubitemid 35232291)
25. Minucci S, Horn V, Bhattacharyya N, Russanova V, Ogryzko VV, et al. (1997) A histone deacetylase inhibitor potentiates retinoid receptor action in embryonal carcinoma cells. Proc Natl Acad Sci U S A 94: 11295-11300. (Pubitemid 27450992)
26. Mathew S, Arandjelovic S, Beyer WF, Gonias SL, Pizzo SV (2003) Characterization of the interaction between alpha2-macroglobulin and fibroblast growth factor-2: the role of hydrophobic interactions. Biochem J 374: 123-129. (Pubitemid 37046936)
27. Mehl JW, O'Connell W, Degroot J (1964) Macroglobulin from Human Plasma Which Forms an Enzymatically Active Compound with Trypsin. Science 145: 821-822.
28. Bhattacharjee G, Asplin IR, Wu SM, Gawdi G, Pizzo SV (2000) The conformation-dependent interaction of alpha 2-macroglobulin with vascular endothelial growth factor. A novel mechanism of alpha 2-macroglobulin/growth factor binding. J Biol Chem 275: 26806-26811.
29. Fontana V, Silva PS, Belo VA, Antonio RC, Ceron CS, et al. (2011) Consistent alterations of circulating matrix metalloproteinases levels in untreated hypertensives and in spontaneously hypertensive rats: a relevant pharmacological target. Basic Clin Pharmacol Toxicol 109: 130-137.
30. Hickey MM, Simon MC (2006) Regulation of angiogenesis by hypoxia and hypoxia-inducible factors. Curr Top Dev Biol 76: 217-257. (Pubitemid 44773777)
31. Barbosa AC, Kim MS, Ertunc M, Adachi M, Nelson ED, et al. (2008) MEF2C, a transcription factor that facilitates learning and memory by negative regulation of synapse numbers and function. Proc Natl Acad Sci U S A 105: 9391-9396.
32. Cante-Barrett K, Pieters R, Meijerink JP (2013) Myocyte enhancer factor 2C in hematopoiesis and leukemia. Oncogene.
33. Lin Q, Schwarz J, Bucana C, Olson EN (1997) Control of mouse cardiac morphogenesis and myogenesis by transcription factor MEF2C. Science 276: 1404-1407. (Pubitemid 27235406)
34. Lucerna M, Pomyje J, Mechtcheriakova D, Kadl A, Gruber F, et al. (2006) Sustained expression of early growth response protein-1 blocks angiogenesis and tumor growth. Cancer Res 66: 6708-6713. (Pubitemid 44085628)
35. Urbich C, Rossig L, Kaluza D, Potente M, Boeckel JN, et al. (2009) HDAC5 is a repressor of angiogenesis and determines the angiogenic gene expression pattern of endothelial cells. Blood 113: 5669-5679.
36. Mocchegiani E, Giacconi R, Costarelli L (2011) Metalloproteases/anti- metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implications. Curr Opin Pulm Med 17 Suppl 1: S11-19.
37. Tchetverikov I, Ronday HK, Van El B, Kiers GH, Verzijl N, et al. (2004) MMP profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis 63: 881-883. (Pubitemid 38850466)
38. Bisaro de Lorenc L, Ramos AM, Sanchez MC, Montenegro R, Chiabrando GA (2005) Structural evaluation of plasma alpha2-macroglobulin in acute pancreatitis. Clin Chem Lab Med 43: 1183-1189. (Pubitemid 41600668)
39. Wang W, Ha CH, Jhun BS, Wong C, Jain MK, et al. (2010) Fluid shear stress stimulates phosphorylation-dependent nuclear export of HDAC5 and mediates expression of KLF2 and eNOS. Blood 115: 2971-2979.
40. Young A, Wu W, Sun W, Benjamin Larman H, Wang N, et al. (2009) Flow activation of AMP-activated protein kinase in vascular endothelium leads to Kruppel-like factor 2 expression. Arterioscler Thromb Vasc Biol 29: 1902-1908.
41. Hayashi M, Kim SW, Imanaka-Yoshida K, Yoshida T, Abel ED, et al. (2004) Targeted deletion of BMK1/ERK5 in adult mice perturbs vascular integrity and leads to endothelial failure. J Clin Invest 113: 1138-1148. (Pubitemid 38544099)
42. Xu Z, Gong J, Maiti D, Vong L, Wu L, et al. (2012) MEF2C ablation in endothelial cells reduces retinal vessel loss and suppresses pathologic retinal neovascularization in oxygen-induced retinopathy. Am J Pathol 180: 2548-2560.
43. Vong LH, Ragusa MJ, Schwarz JJ (2005) Generation of conditional Mef2cloxP/loxP mice for temporal- and tissue-specific analyses. Genesis 43: 43-48. (Pubitemid 41377433)
44. Carmeliet P (2005) Angiogenesis in life, disease and medicine. Nature 438: 932-936.